Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.

21 Mar 2022

Mount Sinai Health System launches new Alopecia Areata Center of Excellence

In an unparalleled effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around the skin condition alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence.

21 Mar 2022

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

A team of scientists from Turkey has recently evaluated the diversity and composition of gut microbiota in children diagnosed with multisystem inflammatory syndrome (MIS-C) and acute coronavirus disease 2019 (COVID-19). They have observed significant alteration in the gut microbiota composition in children with MIS-C. These changes are associated with autoimmunity, metabolic dysfunction, and obesity.

21 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

Exploring the connection between SARS-CoV-2 infection and the human gut microbiome

A recent study assessed the relationship between the human microbiome and COVID-19.

17 Mar 2022

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

A Saint Louis University School of Medicine scientist and SLUCare physician has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to study Short Bowel Syndrome (SBS).

16 Mar 2022

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine.

16 Mar 2022

People living near green spaces have 16% less stroke risk

In contrast, exposure to environmental pollutants such as fine particulate matter, nitrogen dioxide and soot significantly increases the risk of suffering an ischemic stroke.

15 Mar 2022

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Around 500,000 people in the UK live with Inflammatory Bowel Disease (IBD), a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms.

14 Mar 2022

Molecular signature of microorganisms in stool samples could predict pancreatic cancer risk

Pancreatic cancer is not one of the most frequently diagnosed cancers, but it is one of the most lethal due to its early local extension and metastatic behavior.

9 Mar 2022

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Illinois Institute of Technology is receiving a four-year grant from the National Institutes of Health to fund research to develop drug treatments for cholera and other multi-drug-resistant strains of disease-causing bacteria.

8 Mar 2022

Touch-sensing protein in the gut likely plays a key role in constipation

When we eat food, our gut somehow senses its presence to begin shifting it along our digestive tract, but the question has always been – how?

8 Mar 2022

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

Researchers identify oropharyngeal bacteria and metabolic pathways that are predictive of the need for respiratory support in COVID-19 patients.

7 Mar 2022

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies.

7 Mar 2022

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape™ system, the next generation in ChipCytometry™ instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping.

From Bruker Nano Surfaces and Metrology 7 Mar 2022

Community-based approach to genetic testing may have beneficial effects, study finds

In 2010, scientists discovered that African Americans who are born with certain variants of a gene called apolipoprotein L1 (APOL1) have a higher-than-average risk for experiencing chronic kidney disease (CKD).

4 Mar 2022

Taller adults may be more likely to develop colorectal cancer, study finds

A new meta-analysis, or data examination of several independent studies, by Johns Hopkins Medicine researchers adds to evidence that taller adults may be more likely than shorter ones to develop colorectal cancer or colon polyps that can later become malignant.

3 Mar 2022

Some oral bacteria associated with development of high blood pressure in postmenopausal women

Some oral bacteria were associated with the development of hypertension, also known as high blood pressure, in postmenopausal women, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

2 Mar 2022

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

Researchers from different countries performed a meta-analysis of real-world cross-cohorts and provided an association of the gut microbiome with immune checkpoint inhibitors response in patients with advanced melanomas.

2 Mar 2022

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced positive top-line results from the Phase 2 part of the Phase 2/3 study of once-daily oral RHB-107 (upamostat) in non-hospitalized symptomatic COVID-19 patients, predominantly conducted in the U.S. (60/61 patients) as well as South Africa.

1 Mar 2022

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Mount Sinai Health System launches new Alopecia Areata Center of Excellence

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Exploring the connection between SARS-CoV-2 infection and the human gut microbiome

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

People living near green spaces have 16% less stroke risk

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Molecular signature of microorganisms in stool samples could predict pancreatic cancer risk

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Touch-sensing protein in the gut likely plays a key role in constipation

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Community-based approach to genetic testing may have beneficial effects, study finds

Taller adults may be more likely to develop colorectal cancer, study finds

Some oral bacteria associated with development of high blood pressure in postmenopausal women

Study explores signature gut microbiome connection with immune checkpoint inhibitor response in advanced melanomas

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Microbiology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in